MarketInOut Stock Screener Log In | Sign Up

GENinCode Plc

LSE • Healthcare • Diagnostics & Research • Quote as of 10/27/2026 16:02
GENinCode Plc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeLSE
Market Capitalization6.02 mln
Float496 mln
Earnings Date06/08/2027

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-5.62
Highly reliable

Relative Strength

79 / 100
Strongly outperforming

Debt / Equity

0.05
Debt-free

Pre-Tax Margin

-208%
Severely loss-making

ROE

-325
Deeply negative

Business Description

GENinCode Plc is a UK-based company founded in 2018 that develops genetic tests designed to predict a patient's risk of developing serious health conditions before symptoms appear. Their tests cover a range of concerns, including heart disease, inherited high cholesterol, blood clotting disorders, and ovarian cancer, giving both patients and doctors the information needed to act early. By combining genetic data with advanced analytical tools, the company helps guide preventative care decisions for people in the UK and across the world.

Key Fundamentals

EPS-1.00
ROE-325
RPS0.00
ROIC-1,444
ROA-156
Interest Cover-1,484
EBITDA, mln-5.24
EV / EBITDA-0.48
EV / EBIT-0.46
Revenue, mln2.60
EV / Revenue0.97

Quote Details

Last 0.65
Change -0.087 (-11.8%)
Open 0.80
Volume 5,800,100
Turnover 3,770,065
Average Volume 2,919,156

Financial Ratios

Pre-Tax Profit Margin-208
Leverage Ratio1.71
Current Ratio2.22
Price / Book2.33
Debt / Equity0.05
Price / Sales1.00

Financial Strength

Altman Z-Score-20.61
Piotroski F-Score 4 / 9
Beneish M-Score-5.62

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.7% 12 / 100   
1 Month -26.55% 2 / 100   
2 Months -18.75% 7 / 100   
6 Months -40.91% 4 / 100   
1 Year -81.43% 1 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog